Biomarker Test Trends and Forecast
The future of the global biomarker test market looks promising with opportunities in the cancer, cardiovascular, infectious diseases, and central nervous systems markets. The global biomarker test market is expected to grow with a CAGR of 12.1% from 2024 to 2030. The major drivers for this market are rise in cancer incidence and increasing funding in biomarker studies and technological advancement.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Biomarker Test by Segment
The study includes a forecast for the global biomarker test by application, end use, and region.
Biomarker Test Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Cancer
• Cardiovascular
• Infectious Diseases
• Central Nervous Systems
• Others
Biomarker Test Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Pharma & Biotech Companies
• Diagnostic Tools Companies
• Healthcare IT/ Big Data Companies
• Clinical Laboratories
• Others
Biomarker Test Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Biomarker Test Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomarker test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomarker test companies profiled in this report include-
• Hoffmann-La Roche
• Novartis
• Pfizer
• Glaxosmithkline
• Ge Healthcare
• Medtronic
• Quest Diagnostics
Biomarker Test Market Insights
Lucintel forecasts that diagnostics tools companies will remain the largest segment due to increasing investments in novel biomarkers and growing support from public and private organizations.
Within this market, cancer will remain the largest region over the forecast period due to growing demand for rapid and accurate diagnostic tool and the high incidence of cancer globally.
North America will remain the largest region over the forecast period due to increasing disease rates and rising public awareness towards the benefits of biomarkers.
Features of the Global Biomarker Test Market
Market Size Estimates: Biomarker test market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Biomarker test market size by application, end use, and region in terms of value ($B).
Regional Analysis: Biomarker test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and regions for the biomarker test market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomarker test market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for biomarker test market?
Answer: The global biomarker test market is expected to grow with a CAGR of 12.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the biomarker test market?
Answer: The major drivers for this market are rise in cancer incidence and increasing funding in biomarker studies and technological advancement.
Q3. What are the major segments for biomarker test market?
Answer: The future of the biomarker test market looks promising with opportunities in the cancer, cardiovascular, infectious diseases, and central nervous systems markets.
Q4. Who are the key biomarker test market companies?
Answer: Some of the key biomarker test companies are as follows:
• Hoffmann-La Roche
• Novartis
• Pfizer
• Glaxosmithkline
• Ge Healthcare
• Medtronic
• Quest Diagnostics
Q5. Which biomarker test market segment will be the largest in future?
Answer: Lucintel forecasts that diagnostics tools companies will remain the largest segment due to increasing investments in novel biomarkers and growing support from public and private organizations.
Q6. In biomarker test market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing disease rates and rising public awareness towards the benefits of biomarkers.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the biomarker test market by application (cancer, cardiovascular, infectious diseases, central nervous systems, and others), end use (pharma & biotech companies, diagnostic tools companies, healthcare IT/ big data companies, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Biomarker Test Market, Biomarker Test Market Size, Biomarker Test Market Growth, Biomarker Test Market Analysis, Biomarker Test Market Report, Biomarker Test Market Share, Biomarker Test Market Trends, Biomarker Test Market Forecast, Biomarker Test Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.